SK287787B6 - Použitie L-karnitínu ako stabilizačného činidla proteínov - Google Patents
Použitie L-karnitínu ako stabilizačného činidla proteínov Download PDFInfo
- Publication number
- SK287787B6 SK287787B6 SK890-2003A SK8902003A SK287787B6 SK 287787 B6 SK287787 B6 SK 287787B6 SK 8902003 A SK8902003 A SK 8902003A SK 287787 B6 SK287787 B6 SK 287787B6
- Authority
- SK
- Slovakia
- Prior art keywords
- carnitine
- crystalline
- lenses
- proteins
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IT2000/000520 WO2002048190A1 (en) | 2000-12-15 | 2000-12-15 | Use of l-carnitine as stabilizing agent of proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK8902003A3 SK8902003A3 (en) | 2003-12-02 |
| SK287787B6 true SK287787B6 (sk) | 2011-09-05 |
Family
ID=11133601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK890-2003A SK287787B6 (sk) | 2000-12-15 | 2000-12-15 | Použitie L-karnitínu ako stabilizačného činidla proteínov |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7833977B2 (es) |
| EP (1) | EP1341813B1 (es) |
| AT (1) | ATE339445T1 (es) |
| AU (1) | AU2001223953A1 (es) |
| CA (1) | CA2434911C (es) |
| CY (1) | CY1106235T1 (es) |
| DE (1) | DE60030787T2 (es) |
| DK (1) | DK1341813T3 (es) |
| ES (1) | ES2272351T3 (es) |
| HU (1) | HU230002B1 (es) |
| MX (1) | MXPA03006266A (es) |
| PL (1) | PL199984B1 (es) |
| PT (1) | PT1341813E (es) |
| SK (1) | SK287787B6 (es) |
| WO (1) | WO2002048190A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861403B2 (en) | 2000-05-03 | 2005-03-01 | Expressive Constructs, Inc. | Method and device for improving protein stability and solubility |
| PL199984B1 (pl) | 2000-12-15 | 2008-11-28 | Sigma Tau Ind Farmaceuti | Zastosowanie L-karnityny jako czynnika stabilizującego białka |
| EP1624886A2 (en) * | 2003-05-12 | 2006-02-15 | Expressive Constructs, Inc. | Methods for increasing cell and tissue viability |
| WO2011075430A1 (en) * | 2009-12-14 | 2011-06-23 | University Of Massachusetts | Methods of inhibiting cataracts and presbyopia |
| US20200140500A1 (en) * | 2012-07-17 | 2020-05-07 | The Regents Of The University Of Michigan | High throughput methods, protein inhibitors, and uses thereof |
| WO2014152818A1 (en) | 2013-03-14 | 2014-09-25 | The University Of Massachusetts | Methods of inhibiting cataracts and presbyopia |
| MX2018005903A (es) | 2015-11-13 | 2019-04-04 | Univ Massachusetts | Moléculas bifuncionales que contienen peg para uso en la inhibición de cataratas y presbicia. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1235153B (it) * | 1988-11-15 | 1992-06-22 | Sigma Tau Ind Farmaceuti | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento |
| US20040058015A1 (en) | 2000-06-01 | 2004-03-25 | Yuanjin Tao | Compositions and methods for treating eye discomfort and eye disease |
| PL199984B1 (pl) | 2000-12-15 | 2008-11-28 | Sigma Tau Ind Farmaceuti | Zastosowanie L-karnityny jako czynnika stabilizującego białka |
| ITRM20010294A1 (it) | 2001-05-29 | 2002-11-29 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnetina in associazione con la biotina per il trattamento di pazienti affetti da diabete mellito di tipo ii insulino re |
| US6923960B2 (en) | 2001-10-03 | 2005-08-02 | Vsl Pharmaceuticals Inc. | Antioxidant combination composition and use thereof |
| WO2006121421A2 (en) | 2004-01-14 | 2006-11-16 | Robert Ritch | Methods and formulations for treating glaucoma |
| ITRM20040327A1 (it) | 2004-07-01 | 2004-10-01 | Sigma Tau Ind Farmaceuti | Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici. |
| US8569366B2 (en) | 2005-04-26 | 2013-10-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Acetyl L-carnitine for prevention of painful peripheral neuropathy in patients with type 2 diabetes |
-
2000
- 2000-12-15 PL PL367204A patent/PL199984B1/pl unknown
- 2000-12-15 PT PT00987614T patent/PT1341813E/pt unknown
- 2000-12-15 DK DK00987614T patent/DK1341813T3/da active
- 2000-12-15 EP EP00987614A patent/EP1341813B1/en not_active Expired - Lifetime
- 2000-12-15 AT AT00987614T patent/ATE339445T1/de active
- 2000-12-15 AU AU2001223953A patent/AU2001223953A1/en not_active Abandoned
- 2000-12-15 ES ES00987614T patent/ES2272351T3/es not_active Expired - Lifetime
- 2000-12-15 WO PCT/IT2000/000520 patent/WO2002048190A1/en active IP Right Grant
- 2000-12-15 US US10/470,999 patent/US7833977B2/en not_active Expired - Fee Related
- 2000-12-15 HU HU0400737A patent/HU230002B1/hu not_active IP Right Cessation
- 2000-12-15 SK SK890-2003A patent/SK287787B6/sk not_active IP Right Cessation
- 2000-12-15 CA CA002434911A patent/CA2434911C/en not_active Expired - Fee Related
- 2000-12-15 MX MXPA03006266A patent/MXPA03006266A/es active IP Right Grant
- 2000-12-15 DE DE60030787T patent/DE60030787T2/de not_active Expired - Lifetime
-
2006
- 2006-11-03 CY CY20061101592T patent/CY1106235T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0400737A3 (en) | 2013-06-28 |
| PL199984B1 (pl) | 2008-11-28 |
| HUP0400737A2 (hu) | 2004-07-28 |
| AU2001223953A1 (en) | 2002-06-24 |
| PL367204A1 (en) | 2005-02-21 |
| CA2434911C (en) | 2009-12-08 |
| US7833977B2 (en) | 2010-11-16 |
| SK8902003A3 (en) | 2003-12-02 |
| EP1341813A1 (en) | 2003-09-10 |
| DE60030787T2 (de) | 2007-09-13 |
| DE60030787D1 (de) | 2006-10-26 |
| ES2272351T3 (es) | 2007-05-01 |
| WO2002048190A1 (en) | 2002-06-20 |
| HU230002B1 (en) | 2015-04-28 |
| US20040120967A1 (en) | 2004-06-24 |
| CY1106235T1 (el) | 2011-06-08 |
| PT1341813E (pt) | 2007-01-31 |
| MXPA03006266A (es) | 2004-06-25 |
| DK1341813T3 (da) | 2007-01-15 |
| CA2434911A1 (en) | 2002-06-20 |
| ATE339445T1 (de) | 2006-10-15 |
| EP1341813B1 (en) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trelstad et al. | Isolation of two distinct collagens from chick cartilage | |
| Kannan et al. | Novel roles for α-crystallins in retinal function and disease | |
| Currie et al. | Characterization of the synthesis and accumulation of a 71-kilodalton protein induced in rat tissues after hyperthermia | |
| KR100864380B1 (ko) | 두뇌기능 향상과 뇌신경계 질환 예방 또는 치료용 펩타이드 | |
| US6472436B1 (en) | Methods for protecting cells from amyloid toxicity and for inhibiting amyloid protein production | |
| Moura et al. | The close interplay of nitro-oxidative stress, advanced glycation end products and inflammation in inflammatory bowel diseases | |
| Cao et al. | Effects of L-carnitine on high glucose-induced oxidative stress in retinal ganglion cells | |
| Pasquali-Ronchetti et al. | Pseudoxanthoma elasticum: biochemical and ultrastructural studies | |
| Peluso et al. | Carnitine protects the molecular chaperone activity of lens α‐crystallin and decreases the posttranslational protein modifications induced by oxidative stress | |
| US20100210531A1 (en) | Agents with angiogenic and wound healing activity | |
| SK287787B6 (sk) | Použitie L-karnitínu ako stabilizačného činidla proteínov | |
| Ghosh et al. | Crowded milieu prevents fibrillation of hen egg white lysozyme with retention of enzymatic activity | |
| Castino et al. | Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene | |
| Ringvold | A preliminary report on the amino acid composition of the pseudo-exfoliation material (PE material) | |
| Shun-Shin et al. | Morphologic characteristics and chemical composition of Christmas tree cataract. | |
| RU2627769C1 (ru) | 9-Бензил-2-бифенилимидазо[1,2-а]бензимидазол и его фармацевтически приемлемые соли, проявляющие свойства разрушителей поперечных сшивок гликированных белков | |
| Raju et al. | Role of αA-crystallin-derived αA66-80 peptide in guinea pig lens crystallin aggregation and insolubilization | |
| EP3156064B1 (en) | Application of yb-1 protein and fragments thereof for preparing medicinal agents in treating alzheimer's disease | |
| CZ20031891A3 (cs) | Použití L-karnitinu jako stabilizátoru proteinů | |
| WO2006132205A1 (ja) | ラジカルスカベンジャー及び活性酸素消去剤 | |
| Williams | Studies on azide, caeruloplasmin and copper in relation to Wilson's disease. | |
| RU2797514C1 (ru) | Фармакологическая субстанция мембранотропных гомеостатических тканеспецифических биорегуляторов, выделенных из различных тканей и биологических жидкостей животных | |
| RU2727159C1 (ru) | Композиция полипептидов, обладающая свойством нормализовать функции головного мозга | |
| EP0610481A1 (en) | Extraction of collagen | |
| Parkhomenko et al. | Application of fluorescent potential-sensitive probes for the study of living cells. Cell Ther Transplant 2023; 12 (1): 60-67 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20161215 |